658
Views
7
CrossRef citations to date
0
Altmetric
Review

Home oxygen therapy: evidence versus reality

, &
Pages 425-441 | Received 06 Feb 2017, Accepted 27 Apr 2017, Published online: 10 May 2017

References

  • Karamanou M, Androutsos G. Antoine-Laurent de Lavoisier (1743–1794) and the birth of respiratory physiology. Thorax. 2013;68(10):978–979.
  • Barach AL. Symposium-inhalational therapy. Historical background. Anesthesiology. 1962;23:407–421.
  • Petty TL, Burtis BB, Bigelow DB. Oxygen, an important pharmacologic agent. Rocky Mt Med J. 1967;64(2):66–71.
  • Priestley J. Encycl Britan. 1997;9:696–697. [cited 2017 May 5]. Available from: https://www.britannica.com/biography/Joseph-Priestley
  • Karamanou M, Tsoucalas G, Androutsos G. Hallmarks in the study of respiratory physiology and the crucial role of Antoine-Laurent de Lavoisier (1743–1794). Am J Physiol Lung Cell Mol Physiol. 2013;305(9):L591–L594.
  • Petty TL, McCoy RW, Doherty DE. Long term oxygen therapy (LTOT) history, scientific foundations, and emerging technologies. 6th Oxygen Consensus Conference Recommendations. [cited 2016 Dec 30]. Available from: http://www.nlhep.org/Documents/lt_oxygen.pdf
  • Foreword: a new kind of special issue. Respir Care. 1986;31:761–763.
  • Cotes JE, Gilson JC. Effect of oxygen on exercise ability in chronic respiratory insufficiency; use of portable apparatus. Lancet. 1956;270(6928):872–876.
  • Levine BE, Bigelow DB, Hamstra RD, et al. The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxemia. Ann Int Med. 1967;66(4):639–650.
  • Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Int Med. 1980;93(3):391–398.
  • Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981;1(8222):681–686.
  • Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987;42(2):105–110.
  • Ström K. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am Rev Respir Dis. 1993;147(3):585–591.
  • Gulbas G, Gunen H, In E, et al. Long-term follow-up of chronic obstructive pulmonary disease patients on long-term oxygen treatment. Int J Clin Pract. 2012;66(2):152–157.
  • Górecka D, Gorzelak K, Sliwiński P, et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax. 1997;52(8):674–679.
  • Chaouat A, Weitzenblum E, Kessler R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999;14(5):1002–1008.
  • Long-Term Oxygen Treatment Trial Research G. A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med. 2016;375(17):1617–1627.
  • Hardinge M, Annandale J, Bourne S, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax. 2015;70(Suppl 1):i1–i43.
  • Fleetham JA, Bradley CA, Kryger MH, et al. The effect of low flow oxygen therapy on the chemical control of ventilation in patients with hypoxemic COPD. Am Rev Respir Dis. 1980;122(6):833–840.
  • Ahmadi Z, Bornefalk-Hermansson A, Franklin KA, et al. Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study. Respir Res. 2014;15:30.
  • Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014;2(9):698–705.
  • Windisch W, Storre JH, Köhnlein T. Nocturnal non-invasive positive pressure ventilation for COPD. Expert Rev Respir Med. 2015;9(3):295–308.
  • Murphy P, Arbane G, Bourke S, et al. LATE-BREAKING ABSTRACT: improving admission free survival with home mechanical ventilation (HMV) and home oxygen therapy (HOT) following life threatening COPD exacerbations: hoT-HMV UK Trial NCT00990132. Eur Respir J. 2016;48(Suppl 60):OA3527.
  • MacNee W, Morgan AD, Wathen CG, et al. Right ventricular performance during exercise in chronic obstructive pulmonary disease. The effects of oxygen. Respiration. 1985;48(3):206–215.
  • Fletcher EC, Luckett RA, Goodnight-White S, et al. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis. 1992;145(5):1070–1076.
  • Calverley PM, Brezinova V, Douglas NJ, et al. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis. 1982;126(2):206–210.
  • Walterspacher S, July J, Kohlhäufl M, et al. The severe respiratory insufficiency questionnaire for subjects with COPD with long-term oxygen therapy. Respir Care. 2016;61(9):1186–1191.
  • Nonoyama ML, Brooks D, Lacasse Y, et al. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007;(2):CD005372.
  • Cullen DL. Long term oxygen therapy adherence and COPD: what we don’t know. Chron Respir Dis. 2006;3(4):217–222.
  • Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient’s perspective. J Gen Int Med. 2002;17(10):749–755.
  • Katsenos S, Constantopoulos SH. Long-term oxygen therapy in COPD: factors affecting and ways of improving patient compliance. Pulm Med. 2011;2011:325-362.
  • Clark AL, Johnson M, Fairhurst C, et al. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure. Health Technol Assess. 2015;19(75):1–120.
  • Magnussen H, Kirsten A-M, Köhler D, et al. Guidelines for long-term oxygen therapy. Pneumologie. 2008;62(12):748–756.
  • Chuchalin AG, Avdeev SN, Belevskiy AS, et al. Russian respiratory society federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. 2014. [cited 2016 Dec 30]. Available from: http://journal.pulmonology.ru/pulm/article/viewFile/385/384
  • McDonald CF, Crockett AJ, Young IH. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med J Aust. 2005;182(12):621–626.
  • MacNee W. Lothian guideline for domiciliary oxygen therapy service for COPD. 2009. Version: 1.0. Date of authorisation: 2009 22 Jul. Review date: 2010 Nov. [cited 2016 Dec 30]. Available from: http://www.lothianrespiratorymcn.scot.nhs.uk/wp-content/uploads/2010/01/Lothian-Guideline-for-the-Domiciliary-Oxygen-Therapy-Service-for-COPD.pdf
  • Irish Thoracic Society ISoCP, Respiratory Nurses Association of Ireland. Irish guidelines on long term oxygen therapy (LTOT) in adults 2015. Revision number 1. Approval date 2015 Nov 13. Next Revision date 2017 Nov. [cited 2016 Dec 30]. Available from: http://www.irishthoracicsociety.com/images/uploads/LTOT%20guideline%202015.pdf
  • Nederlands Vereniging van Artsen voor Longziekten en Tuberculose. Richtlijn Diagnostiek en behandeling van COPD. Version 2010 Mar. [cited 2016 Dec 30]. Available from: https://www.nvalt.nl/kwaliteit/richtlijnen/copd-astma-allergie//COPD%20-%20astma%20-%20allergie/Richtlijn-Diagnostiek-en-behandeling-van-COPD-maart-2010.pdf
  • Ortega Ruiz F, Díaz Lobato S, Galdiz Iturri JB, et al. Continuous home oxygen therapy. Arch Bronconeumol. 2014;50(5):185–200.
  • Arbeitsgruppe langfristige Sauerstoffheimtherapie der Schweizerischen Gesellschaft für Pneumologie und der Schweizerischen Gesellschaft für Pädiatrische Pneumologie. Revidierte Richtlinie für die langfristige Sauerstoffheimtherapie. Schweiz Med Wschr. 1997;127:871–875. Ersetzt den Text vom 1996 Sep 20. Available from: http://www.pneumo.ch/de/informationen-fuer-fachpersonen/sgp-richtlinien/sauerstoff.html
  • O’Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2008 update – highlights for primary care. Can Respir J. 2008;15(Suppl A):1A–8A.
  • Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Int Med. 2011;155(3):179–191.
  • From the global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD). 2016. [cited 2016 Dec 30]. Available from: http://goldcopd.org/
  • National Collaborating Centre for Chronic C. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59(Suppl 1):1–232.
  • Abdool-Gaffar MS, Ambaram A, Ainslie GM, et al. Guideline for the management of chronic obstructive pulmonary disease–2011 update. S Afr Med J. 2011;101(1Pt 2):63–73.
  • Magnet FS, Schwarz SB, Callegari J, et al. Long-term oxygen therapy: comparison of the German and British guidelines. Respiration. 2017 Feb 1;93:253–263. [Epub ahead of print]. DOI:10.1159/000455879
  • Ahmadi Z, Sundh J, Bornefalk-Hermansson A, et al. Long-term oxygen therapy 24 vs 15 h/day and mortality in chronic obstructive pulmonary disease. PLoS One. 2016;11(9):e0163293.
  • Huttmann SE, Windisch W, Storre JH. Techniques for the measurement and monitoring of carbon dioxide in the blood. Ann Am Thorac Soc. 2014;11(4):645–652.
  • Pitkin AD, Roberts CM, Wedzicha JA. Arterialised earlobe blood gas analysis: an underused technique. Thorax. 1994;49(4):364–366.
  • Eaton T, Rudkin S, Garrett JE. The clinical utility of arterialized earlobe capillary blood in the assessment of patients for long-term oxygen therapy. Respir Med. 2001;95(8):655–660.
  • Zavorsky GS, Cao J, Mayo NE, et al. Arterial versus capillary blood gases: a meta-analysis. Respir Physiol Neurobiol. 2007;155(3):268–279.
  • Ekkernkamp E, Welte L, Schmoor C, et al. Spot check analysis of gas exchange: invasive versus noninvasive methods. Respiration. 2015;89(4):294–303.
  • Dar K, Williams T, Aitken R, et al. Arterial versus capillary sampling for analysing blood gas pressures. BMJ. 1995;310(6971):24–25.
  • Muñoz X, Torres F, Sampol G, et al. Accuracy and reliability of pulse oximetry at different arterial carbon dioxide pressure levels. Eur Respir J. 2008;32(4):1053–1059.
  • Roberts CM, Bugler JR, Melchor R, et al. Value of pulse oximetry in screening for long-term oxygen therapy requirement. Eur Respir J. 1993;6(4):559–562.
  • Carlin BW, Clausen JL, Ries AL. The use of cutaneous oximetry in the prescription of long-term oxygen therapy. Chest. 1988;94(2):239–241.
  • Roberts CM, Franklin J, O’Neill A, et al. Screening patients in general practice with COPD for long-term domiciliary oxygen requirement using pulse oximetry. Respir Med. 1998;92(11):1265–1268.
  • Timms RM, Kvale PA, Anthonisen NR, et al. Selection of patients with chronic obstructive pulmonary disease for long-term oxygen therapy. JAMA. 1981;245(24):2514–2515.
  • Guyatt GH, Nonoyama M, Lacchetti C, et al. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med. 2005;172(5):573–580.
  • Chaney JC, Jones K, Grathwohl K, et al. Implementation of an oxygen therapy clinic to manage users of long-term oxygen therapy. Chest. 2002;122(5):1661–1667.
  • Oba Y, Salzman GA, Willsie SK. Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease. Respir Care. 2000;45(4):401–406.
  • Litt EJ, Ziesche R, Happak W, et al. Burning HOT: revisiting guidelines associated with home oxygen therapy. Int J Burns Trauma. 2012;2(3):167–170.
  • Amani H, Lozano DD, Blome-Eberwein S. Brother, have you got a light? Assessing the need for intubation in patients sustaining burn injury secondary to home oxygen therapy. J Burn Care Res. 2012;33(6):e280–285.
  • Nonoyama ML, Brooks D, Guyatt GH, et al. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med. 2007;176(4):343–349.
  • Moore RP, Berlowitz DJ, Denehy L, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax. 2011;66(1):32–37.
  • McDonald CF, Blyth CM, Lazarus MD, et al. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med. 1616-1619;152(5 Pt 1):1995.
  • Sandland CJ, Morgan MD, Singh SJ. Patterns of domestic activity and ambulatory oxygen usage in COPD. Chest. 2008;134(4):753–760.
  • Ringbaek T, Martinez G, Lange P. The long-term effect of ambulatory oxygen in normoxaemic COPD patients: a randomised study. Chron Respir Dis. 2013;10(2):77–84.
  • Eaton T, Garrett JE, Young P, et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J. 2002;20(2):306–312.
  • Ameer F, Carson KV, Usmani ZA, et al. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database Syst Rev. 2014;(60):Cd000238.
  • Elphick HE, Mallory G. Oxygen therapy for cystic fibrosis. Cochrane Database Syst Rev. 2013;(7):CD003884.
  • Bradley JM, O’Neill B. Short term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;(4):CD004356.
  • Marcus CL, Bader D, Stabile MW, et al. Supplemental oxygen and exercise performance in patients with cystic fibrosis with severe pulmonary disease. Chest. 1992;101(1):52–57.
  • Dyer F, Callaghan J, Cheema K, et al. Ambulatory oxygen improves the effectiveness of pulmonary rehabilitation in selected patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2012;9(2):83–91.
  • McKeon JL, Murree-Allen K, Saunders NA. Supplemental oxygen and quality of sleep in patients with chronic obstructive lung disease. Thorax. 1989;44(3):184–188.
  • Fletcher EC, Donner CF, Midgren B, et al. Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest. 1992;101(3):649–655.
  • Zinman R, Corey M, Coates AL, et al. Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr. 1989;114(3):368–377.
  • Spier S, Rivlin J, Hughes D, et al. The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis. Am Rev Respir Dis. 1984;129(5):712–718.
  • Gozal D. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J. 1999-2003;10(9):1997.
  • Vázquez JC, Pérez-Padilla R. Effect of oxygen on sleep and breathing in patients with interstitial lung disease at moderate altitude. Respiration. 2001;68(6):584–589.
  • Smith PE, Edwards RH, Calverley PM. Oxygen treatment of sleep hypoxaemia in Duchenne muscular dystrophy. Thorax. 1989;44(12):997–1001.
  • Krachman SL, Nugent T, Crocetti J, et al. Effects of oxygen therapy on left ventricular function in patients with Cheyne-Stokes respiration and congestive heart failure. J Clin Sleep Med. 2005;1(3):271–276.
  • Javaheri S, Ahmed M, Parker TJ, et al. Effects of nasal O2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep. 1999;22(8):1101–1106.
  • Hanly PJ, Millar TW, Steljes DG, et al. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Int Med. 1989;111(10):777–782.
  • Staniforth AD, Kinnear WJ, Starling R, et al. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J. 1998;19(6):922–928.
  • Broström A, Hubbert L, Jakobsson P, et al. Effects of long-term nocturnal oxygen treatment in patients with severe heart failure. J Cardiovasc Nurs. 2005;20(6):385–396.
  • Paul B, Joseph M, De Pasquale CG. Domiciliary oxygen therapy improves sub-maximal exercise capacity and quality of life in chronic heart failure. Heart Lung Circ. 2008;17(3):220–223.
  • Sasayama S, Izumi T, Matsuzaki M, et al. Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J. 2009;73(7):1255–1262.
  • Suzuki J, Ishihara T, Sakurai K, et al. Oxygen therapy prevents ventricular arrhythmias in patients with congestive heart failure and sleep apnea. Circ J. 2006;70(9):1142–1147.
  • Storre JH, Huttmann SE, Ekkernkamp E, et al. Oxygen supplementation in noninvasive home mechanical ventilation: the crucial roles of CO2 exhalation systems and leakages. Respir Care. 2014;59(1):113–120.
  • Lacasse Y, Bernard S, Series F, et al. Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial. BMC Pulm Med. 2017;17(1):8.
  • Philip J, Gold M, Milner A, et al. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage. 2006;32(6):541–550.
  • Currow DC, Agar M, Smith J, et al. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliat Med. 2009;23(4):309–316.
  • Uronis HE, Currow DC, McCrory DC, et al. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer. 2008;98(2):294–299.
  • Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010;376(9743):784–793.
  • Clemens KE, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study. Support Care Cancer. 2009;17(4):367–377.
  • Nandi K, Smith AA, Crawford A, et al. Oxygen supplementation before or after submaximal exercise in patients with chronic obstructive pulmonary disease. Thorax. 2003;58(8):670–673.
  • Quantrill SJ, White R, Crawford A, et al. Short burst oxygen therapy after activities of daily living in the home in chronic obstructive pulmonary disease. Thorax. 2007;62(8):702–705.
  • Stevenson NJ, Calverley PM. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax. 2004;59(8):668–672.
  • Evans TW, Waterhouse JC, Carter A, et al. Short burst oxygen treatment for breathlessness in chronic obstructive airways disease. Thorax. 1986;41(8):611–615.
  • O’Driscoll BR, Neill J, Pulakal S, et al. A crossover study of short burst oxygen therapy (SBOT) for the relief of exercise-induced breathlessness in severe COPD. BMC Pulm Med. 2011;11:23.
  • Lewis CA, Eaton TE, Young P, et al. Short-burst oxygen immediately before and after exercise is ineffective in nonhypoxic COPD patients. Eur Respir J. 2003;22(4):584–588.
  • Ekstrom M, Ahmadi Z, Bornefalk-Hermansson A, et al. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. Cochrane Database Syst Rev. 2016;11:Cd006429.
  • Eaton T, Fergusson W, Kolbe J, et al. Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study. Eur Respir J. 2006;27(4):697–704.
  • Rozen TD. High oxygen flow rates for cluster headache. Neurology. 2004;63(3):593.
  • Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache. 1981;21(1):1–4.
  • Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA. 2009;302(22):2451–2457.
  • Backx AP, Haane DY, De Ceuster L, et al. Cluster headache and oxygen: is it possible to predict which patients will be relieved? A retrospective cross-sectional correlation study. J Neurol. 2010;257(9):1533–1542.
  • Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol. 1985;42(4):362–363.
  • Pesce LI, Bassi GN, Santovito A. Clinical usefulness of a new portable oxygen concentrator. Monaldi Arch Chest Dis. 1994;49(5):444–446.
  • Home controls of a sample of 2,414 oxygen concentrators. Sous-commission technique ANTADIR. Eur Respir J. 1991;4(2):227–231.
  • Burioka N, Takano K, Hoshino E, et al. Clinical utility of a newly developed pressure swing adsorption-type oxygen concentrator with a membrane humidifier. Respiration. 1997;64(4):268–272.
  • Burioka N, Takano K, Suyama H, et al. Efficacy of newly developed pressure swing adsorption type oxygen concentrator with membrane humidifier: comparison with conventional oxygen concentrator with bubble water humidifier. Int Med. 1997;36(12):861–864.
  • Hall LW, Kellagher RE, Fleet KJ. A portable oxygen generator. Anaesthesia. 1986;41(5):516–518.
  • Gould GA, Scott W, Hayhurst MD, et al. Technical and clinical assessment of oxygen concentrators. Thorax. 1985;40(11):811–816.
  • Johns DP, Rochford PD, Streeton JA. Evaluation of six oxygen concentrators. Thorax. 1985;40(11):806–810.
  • Vergeret J, Brambilla C, Mounier L. Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy. Eur Respir J. 1989;2(1):20–25.
  • Lock SH, Blower G, Prynne M, et al. Comparison of liquid and gaseous oxygen for domiciliary portable use. Thorax. 1992;47(2):98–100.
  • Casaburi R, Porszasz J, Hecht A, et al. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD. 2012;9(1):3–11.
  • Cuvelier A, Nuir J-F, Chakroun N, et al. Refillable oxygen cylinders may be an alternative for ambulatory oxygen therapy in COPD. Chest. 2002;122(2):451–456.
  • Strickland SL, Hogan TM, Hogan RG, et al. A randomized multi-arm repeated-measures prospective study of several modalities of portable oxygen delivery during assessment of functional exercise capacity. Respir Care. 2009;54(3):344–349.
  • Nasilowski J, Przybylowski T, Zielinski J, et al. Comparing supplementary oxygen benefits from a portable oxygen concentrator and a liquid oxygen portable device during a walk test in COPD patients on long-term oxygen therapy. Respir Med. 2008;102(7):1021–1025.
  • Katsenos S, Charisis A, Daskalopoulos G, et al. Long-term oxygen therapy in chronic obstructive pulmonary disease: the use of concentrators and liquid oxygen systems in north-western Greece. Respiration. 2006;73(6):777–782.
  • Czajkowska-Malinowska M, Połtyn B, Ciesielska A, et al. [Comparison of the results of long term oxygen therapy in patients treated sequentially using stationary or a portable source of oxygen]. Pneumonol Alergol Pol. 2012;80(4):308–316.
  • Andersson A, Ström K, Brodin H, et al. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis. Eur Respir J. 1998;12(6):1284–1289.
  • Moore-Gillon JC, George RJ, Geddes DM. An oxygen conserving nasal cannula. Thorax. 1985;40(11):817–819.
  • Gloeckl R, Heinzelmann I, Matthaei M, et al. Benefits of an oxygen reservoir cannula versus a conventional nasal cannula during exercise in hypoxemic COPD patients: a crossover trial. Respiration. 2014;88(5):399–405.
  • Domingo C, Roig J, Coll R, et al. Evaluation of the use of three different devices for nocturnal oxygen therapy in COPD patients. Respiration. 1996;63(4):230–235.
  • Roberts CM, Bell J, Wedzicha JA. Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking. Thorax. 1996;51(8):831–834.
  • Braun SR, Spratt G, Scott GC, et al. Comparison of six oxygen delivery systems for COPD patients at rest and during exercise. Chest. 1992;102(3):694–698.
  • Marti S, Pajares V, Morante F, et al. Are oxygen-conserving devices effective for correcting exercise hypoxemia? Respir Care. 1606-1613;58(10):2013.
  • Chatburn RL, Lewarski JS, McCoy RW. Nocturnal oxygenation using a pulsed-dose oxygen-conserving device compared to continuous flow. Respir Care. 2006;51(3):252–256.
  • Franklin KA, Gustafson T, Ranstam J, et al. Survival and future need of long-term oxygen therapy for chronic obstructive pulmonary disease–gender differences. Respir Med. 2007;101(7):1506–1511.
  • Ekström MP, Hermansson AB, Ström KE. Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):715–720.
  • Goldberg AI. Outcomes of home care for life-supported persons: long-term oxygen and prolonged mechanical ventilation. Chest. 1996;109(3):595–596.
  • Ringbaek TJ, Lange P. Trends in long-term oxygen therapy for COPD in Denmark from 2001 to 2010. Respir Med. 2014;108(3):511–516.
  • Gustafson T, Löfdahl K, Ström K. A model of quality assessment in patients on long-term oxygen therapy. Respir Med. 2009;103(2):209–215.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.